Situated among one of the world’s largest neuroscience communities, the Massachusetts General Hospital provides an array of neurotherapeutic treatments for our varied patient populations. Experts from the Department of Neurology, Department of Neurosurgery, Department of Psychiatry, the Athinoula A. Martinos Center for Biomedical Imaging and beyond develop and implement neurotherapeutics and associated diagnostics for individuals with complex brain disorders affecting cognition, behavior, emotion, sensory and motor functioning.
The ALS Multidisciplinary Clinic in the Healey Center for ALS at Mass General provides personalized care and access to the latest treatments and research opportunities for people with ALS, commonly known as Lou Gehrig’s disease.
The Mass General Epilepsy Service offers diagnosis, treatment, and consultations for seizure disorders, including surgical evaluations, and specialized care for first seizure events.
Our lab, led by Bakhos Tannous, PhD, focuses on molecular imaging, gene transfer technologies and high throughput screening aiming at finding novel therapeutics against brain tumors.
Our lab is focused on understanding neural repair mechanisms and outcomes after stroke in order to guide the development and clinical translation of novel neurotechnologies to optimize stroke recovery.
The Movement Disorders Unit at Mass General sees patients from around the world for everything from the most common to the rarest of movement disorders.
The Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital is dedicated to finding new treatments for bipolar disorder, providing high-quality clinical care and educating our colleagues, our patients, their families and the community about this disorder.
The Intravenous (IV) Ketamine Clinic for Depression at Massachusetts General Hospital offers patients and their professional providers access to ketamine treatment for severe and refractory depression.
The mission of the Pediatric Psychopharmacology and Adult ADHD Program at Massachusetts General Hospital is to advance the well-being of children and families afflicted with mental illness through research, education and clinical care.
The TMS Clinical Service at Massachusetts General Hospital provides non-invasive treatment for patients with major depressive disorder who are unable to find relief through antidepressant medications or psychotherapy.
Additional Neurotherapeutic Clinical Therapies and Research
The Mass General for Children Epilepsy Surgery Program provides surgical evaluation and treatment for pediatric patients whose epilepsy cannot be managed with medical therapy or those for whom surgery is the best option overall.
For several decades the Massachusetts General Hospital Department of Neurosurgery and Department of Neurology have led in patient care for those with Parkinson's disease and advancing clinical research to develop new treatments with the hope of creating a cure.
2,000 + Researchers
Unparalleled Research Capabilities
We push scientific boundaries by training the best minds in the world
500+ Biotech Companies
Massachusetts Biotech Ecosystem
Worlds largest concentration of biotechnology and research centers.
1,200 + CLINICAL TRIALS
Mass General has 1,200 clinical trials taking place at any given time.
In this large-scale comparative effectiveness trial, researchers demonstrated the equivalence of delivering early palliative care via video versus in-person visits on quality of life in patients with advanced lung cancer.
The algorithm showed proof-of-concept potential in distinguishing individuals with FND, which is a first step in potentially using structural brain MRI to assist in the diagnosis of FND.
Researchers have introduced a blood-based test that allows for the minimally invasive detection of tumor-derived extracellular RNA using only 2ml of blood.
Together with Les Turner ALS Center at Northwestern Medicine, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital is thrilled to announce the launch of the Acceleration Centers of Enrollment (ACE) initiative